Disclosures for "Alzheimer’s Disease Linkage to Evidence (AD-LINE) Study Early Results: Linking Real-World Claims Data to Phase III GRADUATE Study of Gantenerumab")
-
Chris Wallick has nothing to disclose.
-
Howard Fillit has nothing to disclose.
-
The institution of Prof. Tcheremissine has received research support from Eli Lilly . The institution of Prof. Tcheremissine has received research support from Genentech/Roche. The institution of Prof. Tcheremissine has received research support from Janssen . The institution of Prof. Tcheremissine has received research support from Athira Pharma.
-
Dr. Abbass has received personal compensation for serving as an employee of Genentech.
-
Carmen Ng has received personal compensation for serving as an employee of Genentech. Carmen Ng has stock in Roche.
-
Tu My To has received personal compensation for serving as an employee of Genentech. Tu My To has received stock or an ownership interest from Genentech.
-
Sheila Seleri has received personal compensation for serving as an employee of Genentech, a member of the Roche group. Sheila Seleri has received stock or an ownership interest from Genentech, a member of the Roche group.